Gilead Sciences, Inc. (GILD)
Live and historical stock data for Gilead Sciences, Inc., delivered through Axion's financial data API - pricing, fundamentals, SEC filings, ownership, ETF exposure and sentiment in one JSON response.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provid…
GET /stocks/GILD/pricesGILD Price History
Weekly close prices for Gilead Sciences, Inc., pulled directly from Axion's historical market data API.
GILD Fundamentals - Financial Analytics API
Multi-year Gilead Sciences, Inc. financial statement data, structured for a quantitative finance API workflow - no PDF parsing or scraping required.
GET /financials/GILD/revenueRevenue & Net Income
Annual revenue vs. net income, sourced from SEC filings.
- Net Income
- Revenue
GET /financials/GILD/cashflow/freeFree Cash Flow vs. CapEx
Cash generated after operating costs vs. capital reinvested into the business.
- CapEx
- Free Cash Flow
GET /financials/GILD/epsEPS Trend (TTM)
Trailing twelve-month earnings per share, by report date.
GET /financials/GILD/roe · /deProfitability & Leverage
Return on equity vs. debt-to-equity, by report date.
- Debt/Equity
- ROE
GILD Valuation - Investment Research API
DCF fair value, analyst consensus and the 52-week trading range for GILD, built for investment research API and trading data API use cases.
GET /financials/dcf/GILD/valueMargin of safety: 0.8%
GET /profiles/GILD/summary52W Range: $107.75 - $157.29
GET /profiles/GILD/recommendationAnalyst Consensus Trend
Strong buy / buy / hold / sell counts across recent trailing periods.
- Buy
- Hold
- Sell
- Strong Buy
ETF & Fund Exposure to GILD
Every mutual fund and ETF reporting a position in GILD, searchable by fund name - a direct look at institutional financial data API coverage for this ticker.
GET /insiders/GILD/funds| Fund / ETF | Shares Held | % Held | Value |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | - | 3.2% | $4.98B |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | - | 2.5% | $3.98B |
| Invesco QQQ Trust, Series 1 | - | 2.2% | $3.40B |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | - | 1.5% | $2.29B |
| iShares Trust-iShares Core S&P 500 ETF | - | 1.3% | $2.03B |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | - | 1.3% | $2.01B |
| Income Fund of America | - | 1.3% | $1.96B |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | - | 1.2% | $1.89B |
| JPMorgan Trust II-JPMorgan Large Cap Growth Fund | - | 1.0% | $1.56B |
| WASHINGTON MUTUAL INVESTORS FUND | - | 1.0% | $1.50B |
Companies Linked to GILD - Trading Data API
Peers, suppliers and customers mapped from Axion's supply chain API, useful for building correlated, cross-company trading data API signals.
- ImageneBio, Inc.IMA
- Zenas BioPharma, Inc.ZBIO
- Anixa Biosciences, Inc.ANIX
- Geron CorporationGERN
- MBX Biosciences, Inc.MBX
- Eloxx Pharmaceuticals, Inc.ELOX
GILD Ownership - Institutional Financial Data API
Insider, institutional and public ownership breakdown, plus the latest insider transactions.
GET /insiders/GILD/ownership- Insiders
- Institutions
- Public / Other
| Insider | Activity | Shares | Value |
|---|---|---|---|
| MERCIER JOHANNA | Sale at price 123.42 - 125.40 per share. | 3.0K | $371.8K |
| DICKINSON ANDREW D | Sale at price 125.40 per share. | 3.0K | $376.2K |
| BERGER DIETMAR P. | 533 | - | |
| MERCIER JOHANNA | 2.8K | - | |
| CAIN WETTAN KEELEY M | 589 | - |
GILD ESG Scores
Environmental, social, governance and controversy scores, pulled from the same financial data API.
GET /esg/GILDESG Score Breakdown
GET /filings/GILDRecent SEC Filings
- 4Aug 11, 2026
- SCHEDULE 13D/AAug 7, 2026
- S-3ASRAug 6, 2026
- 10-QAug 6, 2026
- 4Aug 4, 2026
GET /news/GILDLatest News
- Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine - Yahoo Finance Thu, 13 Aug 2026 21:46:08 GMT
- Monument Capital Management Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat Fri, 14 Aug 2026 10:17:43 GMT
- Gilead Scores Win to Keep Pause on Cheaper, Foreign Drug Imports - Bloomberg Law News Thu, 13 Aug 2026 18:37:00 GMT
- Gilead Sciences Inc. stock outperforms competitors on strong trading day - marketwatch.com Tue, 11 Aug 2026 20:36:00 GMT
- Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail Fri, 14 Aug 2026 04:04:00 GMT
See It In Action - API & Python Example
The same request that powers this page, in cURL, Python and JavaScript, plus an example chart rendered straight from the response.
curl https://api.axionquant.com/stocks/GILD/quote \
-H "Authorization: Bearer YOUR_API_KEY"GET /financials/GILD/revenueRendered from the response above
Revenue vs. net income - the exact data returned by the Python example.
- Historical prices (OHLCV)
- Financial statements & ratios
- DCF valuation & analyst consensus
- Insider & institutional ownership
- ETF & fund exposure
- ESG scores
- Supply chain & peers
- SEC filings
- News, social & analyst sentiment
- Company news
Why Developers Use Axion's Financial Data API
A single stock market API and market data API for pricing, fundamentals and alternative data - built for quant research API and institutional financial data API workflows.
One API, every asset class
Equities, ETFs, crypto, forex and futures through a single financial data API - no juggling vendors.
Institutional-grade fundamentals
Point-in-time financial statements sourced from SEC filings, built for an institutional financial data API workflow.
Built for backtesting
Daily and weekly historical market data going back years, ready for a quantitative finance API pipeline.
Alternative data included
ESG, sentiment, supply chain and insider activity - a financial intelligence API that goes beyond price.
Free tier, real docs
Explore the stock data API for free - grab a key and start pulling market data in minutes.
Research You Can Build on GILD
Starting points for quant research API and investment research API projects using this ticker.
Backtest a strategy on GILD
Pull GILD's full daily price history and combine it with fundamentals to backtest momentum or mean-reversion signals.
Build a DCF valuation model
Feed live revenue, free cash flow and discount-rate inputs into your own model, benchmarked against Axion's DCF fair value.
Screen for Health Technology peers
Use supply-chain and sector classification data to build a comparable-company screen around GILD.
Factor in ESG and sentiment
Combine ESG scores with news and social sentiment to test alternative-data factors against returns.
Track insider conviction
Monitor insider buying and selling activity, plus ETF and institutional ownership shifts, ahead of catalysts.
Map supply-chain risk
Trace GILD's suppliers and customers to model second-order exposure to sector shocks.
Explore More From Axion
One account, every dataset - browse the rest of Axion's market data API and alternative data catalog.
Built for Teams Like These
From independent researchers to institutional desks - Axion powers financial applications at every scale.
GILD Data, Built for Developers and Quant Teams
Gilead Sciences, Inc. pricing, fundamentals and alternative data are available through Axion's financial data API - a single, consistent stock data API and market data API covering equities, ETFs, crypto, forex and futures. Instead of stitching together a stock market API for pricing, a separate SEC filings feed, and a spreadsheet for fundamentals, pull GILD's revenue, EPS, insider activity, ETF exposure, ESG scores and DCF valuation from one financial analytics API.
Axion is built for institutional financial data API and quant research API workflows: point-in-time financial statements for backtesting, a historical market data API with daily and weekly granularity going back years, and an investment research API layer that surfaces analyst consensus, sentiment and ownership changes for GILD alongside every other ticker you track. Whether you're building a quantitative finance API pipeline, a trading data API for a systematic strategy, or a research dashboard, GILD's complete dataset is one authenticated request away.
Frequently asked questions
Does Axion offer a stock market API for GILD?
Yes. Axion's stock data API returns real-time quotes, historical prices, fundamentals, SEC filings, ownership and sentiment for GILD through a single financial data API key.
Can I pull GILD's historical market data programmatically?
Yes - the historical market data API returns daily, weekly, monthly, quarterly or yearly OHLCV bars for GILD, with no fixed lookback limit.
Is GILD's fundamental data suitable for quant research?
Yes. Revenue, net income, free cash flow, ROE and DCF valuation are exposed as structured JSON, ready for a quantitative finance API or quant research API pipeline - no scraping or PDF parsing required.
Can I see which ETFs and funds hold GILD?
Yes. Axion's institutional financial data API includes fund and ETF ownership, insider transactions and major-holder breakdowns for GILD, refreshed alongside SEC filings.